560 related articles for article (PubMed ID: 17393393)
1. Clinical and immunogenetic features of patients with autoantibodies to asparaginyl-transfer RNA synthetase.
Hirakata M; Suwa A; Takada T; Sato S; Nagai S; Genth E; Song YW; Mimori T; Targoff IN
Arthritis Rheum; 2007 Apr; 56(4):1295-303. PubMed ID: 17393393
[TBL] [Abstract][Full Text] [Related]
2. Anti-KS: identification of autoantibodies to asparaginyl-transfer RNA synthetase associated with interstitial lung disease.
Hirakata M; Suwa A; Nagai S; Kron MA; Trieu EP; Mimori T; Akizuki M; Targoff IN
J Immunol; 1999 Feb; 162(4):2315-20. PubMed ID: 9973509
[TBL] [Abstract][Full Text] [Related]
3. Antibodies to glycyl-transfer RNA synthetase in patients with myositis and interstitial lung disease.
Targoff IN; Trieu EP; Plotz PH; Miller FW
Arthritis Rheum; 1992 Jul; 35(7):821-30. PubMed ID: 1622421
[TBL] [Abstract][Full Text] [Related]
4. Clinical, radiological, and pathological features of anti-asparaginyl tRNA synthetase antibody-related interstitial lung disease.
Aiko N; Yamakawa H; Iwasawa T; Takemura T; Okudela K; Kitamura H; Hagiwara E; Ikeda S; Baba T; Iso S; Yamaguchi Y; Kondo Y; Kurabayashi T; Ohashi K; Sato S; Ogura T
Respir Investig; 2020 May; 58(3):196-203. PubMed ID: 32094078
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease.
Hozumi H; Fujisawa T; Nakashima R; Johkoh T; Sumikawa H; Murakami A; Enomoto N; Inui N; Nakamura Y; Hosono Y; Imura Y; Mimori T; Suda T
Respir Med; 2016 Dec; 121():91-99. PubMed ID: 27888997
[TBL] [Abstract][Full Text] [Related]
6. The long-term outcome of interstitial lung disease with anti-aminoacyl-tRNA synthetase antibodies.
Tanizawa K; Handa T; Nakashima R; Kubo T; Hosono Y; Watanabe K; Aihara K; Ikezoe K; Sokai A; Nakatsuka Y; Taguchi Y; Hatta K; Noma S; Kobashi Y; Yoshizawa A; Oga T; Hirai T; Chin K; Nagai S; Izumi T; Mimori T; Mishima M
Respir Med; 2017 Jun; 127():57-64. PubMed ID: 28461123
[TBL] [Abstract][Full Text] [Related]
7. Anti-synthetase syndrome: a new autoantibody to phenylalanyl transfer RNA synthetase (anti-Zo) associated with polymyositis and interstitial pneumonia.
Betteridge Z; Gunawardena H; North J; Slinn J; McHugh N
Rheumatology (Oxford); 2007 Jun; 46(6):1005-8. PubMed ID: 17392287
[TBL] [Abstract][Full Text] [Related]
8. [Clinical value of myositis antibodies in patients with connective tissue disease-associated interstitial lung diseases].
Xie MM; Zou RY; Li Y; Liu Y; Chen LL; Liu XQ; Zhao Q; Ding JJ; Chen ZY; Cai HR
Zhonghua Jie He He Hu Xi Za Zhi; 2019 Oct; 42(10):765-770. PubMed ID: 31594111
[No Abstract] [Full Text] [Related]
9. Clinical and human leucocyte antigen class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target, in UK Caucasian adult-onset myositis.
Betteridge ZE; Gunawardena H; Chinoy H; North J; Ollier WE; Cooper RG; McHugh NJ;
Ann Rheum Dis; 2009 Oct; 68(10):1621-5. PubMed ID: 18930994
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics of Japanese patients with anti-OJ (anti-isoleucyl-tRNA synthetase) autoantibodies.
Sato S; Kuwana M; Hirakata M
Rheumatology (Oxford); 2007 May; 46(5):842-5. PubMed ID: 17255133
[TBL] [Abstract][Full Text] [Related]
11. Reaction of anti-OJ autoantibodies with components of the multi-enzyme complex of aminoacyl-tRNA synthetases in addition to isoleucyl-tRNA synthetase.
Targoff IN; Trieu EP; Miller FW
J Clin Invest; 1993 Jun; 91(6):2556-64. PubMed ID: 8514867
[TBL] [Abstract][Full Text] [Related]
12. Interstitial lung disease with autoantibodies against aminoacyl-tRNA synthetases in the absence of clinically apparent myositis.
Friedman AW; Targoff IN; Arnett FC
Semin Arthritis Rheum; 1996 Aug; 26(1):459-67. PubMed ID: 8870113
[TBL] [Abstract][Full Text] [Related]
13. Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome.
Hamaguchi Y; Fujimoto M; Matsushita T; Kaji K; Komura K; Hasegawa M; Kodera M; Muroi E; Fujikawa K; Seishima M; Yamada H; Yamada R; Sato S; Takehara K; Kuwana M
PLoS One; 2013; 8(4):e60442. PubMed ID: 23573256
[TBL] [Abstract][Full Text] [Related]
14. Unusually high frequency of autoantibodies to PL-7 associated with milder muscle disease in Japanese patients with polymyositis/dermatomyositis.
Yamasaki Y; Yamada H; Nozaki T; Akaogi J; Nichols C; Lyons R; Loy AC; Chan EK; Reeves WH; Satoh M
Arthritis Rheum; 2006 Jun; 54(6):2004-9. PubMed ID: 16732549
[TBL] [Abstract][Full Text] [Related]
15. The pulmonary histopathology of anti-KS transfer RNA synthetase syndrome.
Schneider F; Aggarwal R; Bi D; Gibson K; Oddis C; Yousem SA
Arch Pathol Lab Med; 2015 Jan; 139(1):122-5. PubMed ID: 25549148
[TBL] [Abstract][Full Text] [Related]
16. HLA class II haplotypes associated with pulmonary interstitial lesions of polymyositis/dermatomyositis in Japanese patients.
Horiki T; Ichikawa Y; Moriuchi J; Hoshina Y; Yamada C; Wakabayashi T; Jackson K; Inoko H
Tissue Antigens; 2002 Jan; 59(1):25-30. PubMed ID: 11972875
[TBL] [Abstract][Full Text] [Related]
17. In adult onset myositis, the presence of interstitial lung disease and myositis specific/associated antibodies are governed by HLA class II haplotype, rather than by myositis subtype.
Chinoy H; Salway F; Fertig N; Shephard N; Tait BD; Thomson W; Isenberg DA; Oddis CV; Silman AJ; Ollier WE; Cooper RG;
Arthritis Res Ther; 2006; 8(1):R13. PubMed ID: 16507114
[TBL] [Abstract][Full Text] [Related]
18. Anti-melanoma differentiation-associated protein 5-associated dermatomyositis: expanding the clinical spectrum.
Hall JC; Casciola-Rosen L; Samedy LA; Werner J; Owoyemi K; Danoff SK; Christopher-Stine L
Arthritis Care Res (Hoboken); 2013 Aug; 65(8):1307-15. PubMed ID: 23436757
[TBL] [Abstract][Full Text] [Related]
19. Clinical evaluation of anti-aminoacyl tRNA synthetase antibodies in Japanese patients with dermatomyositis.
Matsushita T; Hasegawa M; Fujimoto M; Hamaguchi Y; Komura K; Hirano T; Horikawa M; Kondo M; Orito H; Kaji K; Saito Y; Matsushita Y; Kawara S; Yasui M; Seishima M; Ozaki S; Kuwana M; Ogawa F; Sato S; Takehara K
J Rheumatol; 2007 May; 34(5):1012-8. PubMed ID: 17309126
[TBL] [Abstract][Full Text] [Related]
20. Comparison of cytokine profiles between anti-ARS antibody-positive interstitial lung diseases and those with anti-MDA-5 antibodies.
Asakawa K; Yoshizawa K; Aoki A; Kimura Y; Tanaka T; Ohashi K; Hayashi M; Kikuchi T; Sato S; Takada T
Clin Rheumatol; 2020 Jul; 39(7):2171-2178. PubMed ID: 32056068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
